Product Program year 2025 Source: CMS Open Payments

Brixadi

Drug Opioid Use Disorder

NDC 58284-224-01

Open in the dashboard

General payments

$3,265,664

31,820 payments

Research payments

$0

0 payments

Through program year 2025, $3,265,664 in general payments and $0 in research payments were reported against Brixadi (Opioid Use Disorder).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $1,701,829 15,923
2024 General $1,220,194 12,568
2023 General $343,641 3,329

Breakdown

Who paid General payments · program years 2023–2025
  1. Braeburn Inc. $3,265,664 31,820 payments
Top recipients General payments · program year 2025
  1. John Rocco Rodney Addiction Medicine · Memphis, TN $136,818 8% · 164 payments
  2. David Deyhimy Anesthesiology · Laguna Hills, CA $125,179 7% · 111 payments
  3. James Lim Family Medicine · Irwin, PA $114,412 7% · 179 payments
  4. Ximena Sanchez-Samper Psychiatry · Boston, MA $105,866 6% · 158 payments
  5. Michael Frost Internal Medicine · Ambler, PA $101,106 6% · 126 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Psychiatry Psychiatry & Neurology $277,873 16% · 396 practitioners
  2. Internal Medicine $250,116 15% · 283 practitioners
  3. Family Medicine $249,348 15% · 591 practitioners
  4. Addiction Medicine Family Medicine $169,868 10% · 134 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $163,304 10% · 1,304 practitioners

The top 5 of 107 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $327,178 19% · 552 recipients
  2. California $204,997 12% · 412 recipients
  3. New York $155,398 9% · 431 recipients
  4. Florida $152,828 9% · 340 recipients
  5. Tennessee $150,072 9% · 193 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

3,713

Prescriptions dispensed, refills included

Drug cost

$5,508,028

Paid at the pharmacy, in all

Prescribers

197

With 11 or more claims of it

Medicare Part D drugs matched to BRIXADI, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Brixadi Buprenorphine Same name 197 3,713 $5,508,028

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
James Hyatt Family Practice LA 62 $104,969 $256
Joshua Morris Hospitalist TN 50 $80,245 $98
Anthony Cesario Nurse Practitioner OH 50 $40,726 $373
Louise Murray Nurse Practitioner PA 48 $79,446 $186
Martha Oates Nurse Practitioner NJ 46 $78,898 $224

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron
31,820 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record